Neogen Corp Investors Urged to Participate in Class Action

Neogen Corporation Class Action Overview
The law firm of Robbins Geller Rudman & Dowd LLP is advocating for purchasers of Neogen Corporation (NASDAQ: NEOG) common stock. Investors who faced significant losses between January 5, 2023, and June 3, 2025, are encouraged to seek the role of lead plaintiff in an upcoming class action lawsuit. This class action is officially titled Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation.
Details on the Allegations Against Neogen
The lawsuit charges Neogen and its top executives with breaching the Securities Exchange Act of 1934. Allegations claim that during the specified Class Period, defendants made misleading statements regarding the company’s operations and its merger with the Food Safety Division of the 3M Company, which took place in September 2022.
Impact of the 3M Merger
In December 2021, Neogen announced its intention to merge with 3M, which was considered crucial for its growth strategy. However, reports indicate that the integration faced significant challenges. Despite these hurdles, Neogen's leadership purportedly conveyed to investors that the integration was proceeding smoothly, which was not the reality.
Financial Results and Market Reaction
On January 10, 2025, Neogen reported its preliminary second-quarter financial results, which resulted in a staggering GAAP net income loss due to a non-cash goodwill impairment charge of $461 million linked to the 3M acquisition. In this announcement, the company also revised its revenue and EBITDA guidance downward, indicating serious internal control flaws over financial reporting.
Subsequent Quarterly Results
Come April 9, 2025, Neogen again faced scrutiny as it reported a net loss of $11 million for its third-quarter results, demonstrating a drastic shift compared to the prior year. Revenue dropped by 3.4% to $221 million, primarily due to the integration difficulties, prompting further cuts in financial projections. This news triggered a sharp decrease of 28% in Neogen’s stock price.
Lead Plaintiff Process for Investors
Per the Private Securities Litigation Reform Act of 1995, any investor who acquired Neogen shares within the Class Period can apply to become the lead plaintiff in this lawsuit. A lead plaintiff represents all investors affected by the alleged misconduct and plays a vital role in the lawsuit’s direction.
Insights on Robbins Geller Firms
Robbins Geller Rudman & Dowd LLP stands as a leading firm in investor protection and securities fraud litigation. They have gained notable recognition for recovering billions for investors in past class actions. Their history of securing significant monetary relief underscores their dedication to safeguarding investors' interests.
Conclusion and Contact Information
Investors who incurred losses and wish to join the class action are encouraged to provide relevant information to Robbins Geller. For those looking for assistance or more details, contacting attorneys J.C. Sanchez or Jennifer N. Caringal at Robbins Geller is advisable. They can be reached at 800-449-4900 or via email at info@rgrdlaw.com.
Frequently Asked Questions
What is the Neogen class action lawsuit about?
The lawsuit centers on allegations of misleading statements made by Neogen's executives regarding their merger with 3M and its implications on financial results.
Who can participate in the class action?
Any investor who purchased Neogen shares during the period from January 5, 2023, to June 3, 2025, is eligible to seek appointment as lead plaintiff.
What are the possible outcomes of this lawsuit?
The lawsuit aims to hold Neogen accountable for any financial losses caused by alleged fraud, potentially resulting in compensation for affected investors.
How does one become the lead plaintiff?
Interested investors must file a motion with the court during the specified lead plaintiff period to take on this role in the lawsuit.
How can I get in touch with Robbins Geller?
Investors can contact J.C. Sanchez or Jennifer N. Caringal at Robbins Geller by calling 800-449-4900 or emailing info@rgrdlaw.com for further inquiries.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.